IRIS Accounts Production v24.3.2.46 13724212 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Ordinary 0.0100 B Ordinary (non-voting) 0.0100 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh137242122023-12-31137242122024-12-31137242122024-01-012024-12-31137242122022-12-31137242122023-01-012023-12-31137242122023-12-3113724212ns15:EnglandWales2024-01-012024-12-3113724212ns14:PoundSterling2024-01-012024-12-3113724212ns10:Director12024-01-012024-12-3113724212ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3113724212ns10:SmallEntities2024-01-012024-12-3113724212ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3113724212ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3113724212ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3113724212ns10:FullAccounts2024-01-012024-12-3113724212ns10:OrdinaryShareClass12024-01-012024-12-3113724212ns10:OrdinaryShareClass22024-01-012024-12-3113724212ns10:Director22024-01-012024-12-3113724212ns10:Director32024-01-012024-12-3113724212ns10:Director42024-01-012024-12-3113724212ns10:RegisteredOffice2024-01-012024-12-3113724212ns5:CurrentFinancialInstruments2024-12-3113724212ns5:CurrentFinancialInstruments2023-12-3113724212ns5:ShareCapital2024-12-3113724212ns5:ShareCapital2023-12-3113724212ns5:SharePremium2024-12-3113724212ns5:SharePremium2023-12-3113724212ns5:RetainedEarningsAccumulatedLosses2024-12-3113724212ns5:RetainedEarningsAccumulatedLosses2023-12-3113724212ns5:ComputerEquipment2024-01-012024-12-3113724212ns5:ComputerEquipment2023-12-3113724212ns5:ComputerEquipment2024-12-3113724212ns5:ComputerEquipment2023-12-3113724212ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3113724212ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3113724212ns10:OrdinaryShareClass12024-12-3113724212ns10:OrdinaryShareClass22024-12-3113724212ns5:RetainedEarningsAccumulatedLosses2023-12-3113724212ns5:SharePremium2023-12-3113724212ns5:RetainedEarningsAccumulatedLosses2024-01-012024-12-311372421212024-01-012024-12-31
REGISTERED NUMBER: 13724212 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Amparo Prosthetics Limited

Amparo Prosthetics Limited (Registered number: 13724212)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Amparo Prosthetics Limited

Company Information
for the Year Ended 31 December 2024







DIRECTORS: S Mead
W Teerlink
F Carpinteiro
S Hawkins





REGISTERED OFFICE: Stokenchurch Business Park
Ibstone Road
Stokenchurch
High Wycombe
Buckinghamshire
HP14 3FE





REGISTERED NUMBER: 13724212 (England and Wales)





ACCOUNTANTS: Kearney & Associates Limited
14 Harvey Road
Bedford
Bedfordshire
MK41 9LF

Amparo Prosthetics Limited (Registered number: 13724212)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 124 225

CURRENT ASSETS
Stocks 91,672 29,060
Debtors 5 576,109 447,674
Cash at bank 36,974 24,772
704,755 501,506
CREDITORS
Amounts falling due within one year 6 642,121 585,499
NET CURRENT ASSETS/(LIABILITIES) 62,634 (83,993 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

62,758

(83,768

)

CAPITAL AND RESERVES
Called up share capital 8 146 142
Share premium 9 342,024 168,447
Retained earnings 9 (279,412 ) (252,357 )
SHAREHOLDERS' FUNDS 62,758 (83,768 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Amparo Prosthetics Limited (Registered number: 13724212)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 14 August 2025 and were signed on its behalf by:





S Mead - Director


Amparo Prosthetics Limited (Registered number: 13724212)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Amparo Prosthetics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Further investment is anticipated in the near future. The directors therefore conclude that there are no material uncertainties which may cast significant doubt regarding the company's ability to continue as a going concern. Accordingly, the company has adopted the going concern basis in preparing the annual report and accounts.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Amparo Prosthetics Limited (Registered number: 13724212)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2024
and 31 December 2024 404
DEPRECIATION
At 1 January 2024 179
Charge for year 101
At 31 December 2024 280
NET BOOK VALUE
At 31 December 2024 124
At 31 December 2023 225

Amparo Prosthetics Limited (Registered number: 13724212)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 19,942 18,909
Amounts owed by group
undertakings

541,031

415,436
Other debtors 11,544 12,425
VAT 2,346 378
Prepayments 1,246 526
576,109 447,674

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Other loans (see note 7) 514,384 482,996
Trade creditors 100,587 73,749
Social security and other taxes 1,558 9,386
Accrued expenses 25,592 19,368
642,121 585,499

7. LOANS

An analysis of the maturity of loans is given below:

31.12.24 31.12.23
£    £   
Amounts falling due within one year or on demand:
Convertible loan notes 233,000 233,000
Other loan 281,384 249,996
514,384 482,996

Whilst the longstop date on the agreements have passed, the convertible loans and loans are expected to either convert into equity or suitable repayment terms to be agreed in the near future.

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
125,476 Ordinary £0.00 1 125 121
21,400 B Ordinary (non-voting) £0.00 1 21 21
146 142

Amparo Prosthetics Limited (Registered number: 13724212)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

8. CALLED UP SHARE CAPITAL - continued

The following fully paid shares were allotted during the period:

2,834 Ordinary shares of £0.001 each at £11.47 per share
2,285 Ordinary shares of £0.001 each at £21.88 per share

9. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 January 2024 (252,357 ) 168,447 (83,910 )
Deficit for the year (27,055 ) (27,055 )
Cash share issue - 82,497 82,497
Advanced subscription
agreement

-

91,080

91,080

At 31 December 2024 (279,412 ) 342,024 62,612

10. RELATED PARTY DISCLOSURES

During the year to 31 December 2023 W Teerlink, a director of the company, waived an amount previously loaned by himself to Amparo Prosthetics Limited, in the sum of £44,453, in order to facilitate the working capital of the company.


11. POST BALANCE SHEET EVENTS

Post the year end the company acquired a strategic partner in Portugal called Adtechnologies Unipessoal Lda to support logistics and product development.

12. SHARE-BASED PAYMENT TRANSACTIONS

During the year the company implemented an equity-settled share-based payment plan.

During the year the company granted 4166 share options to staff under this plan. Options vest on a combination ot time and other milestones.

The directors have considered recognising a charge in respect of share based payments. However the directors have agreed that any such charge is not material to the accounts and therefore it has not been included.